\-\ Texto\\:\\ \ \(0\)\
\-\ notable\\ only\\ for\\ 3x3\\.5cm\\ firm\\ nodule\\ in\\ level\\ 2\\ region\\.\\ \\ nasopharyngoscope\\ exam\\ was\\ benign\\.\ \(0\)\
\-\ this\\ patient\\ has\\ t2n2am0\\ or\\ stage\\ iva\\ disease\\.\\ \\ surgical\\ excision\\ or\\ combined\\ chemoradiation\\ are\\ the\\ accepted\\ treatment\\ options\\.\\ \\ given\\ liklihood\\ of\\ severe\\ morbidity\\ post\\-surgery\\,\\ patient\\ chose\\ chemoradiation\\.\\ \\ however\\,\\ left\\ neck\\ dissection\\ is\\ still\\ a\\ possibility\\.\\ \\ patient\\ will\\ have\\ imrt\\ m\\-f\\ for\\ about\\ 8\\ weeks\\ and\\ opted\\ for\\ amifostine\\ for\\ parotid\\ sparing\\.\\ \\ patient\\ will\\ have\\ lifetime\\ follow\\-up\\ to\\ monitor\\ for\\ recurrent\\ and\\ new\\ primary\\ disease\\.\ \(0\)\
\-\ neck\\ ct\\:\\ mass\\ adjacent\\ to\\ left\\ parotid\\ and\\ medial\\ to\\ digastric\\ measuring\\ 2\\.8\\ \\(ap\\)x\\ 1\\.6\\ \\(trans\\)x\\ 4\\.5cm\\(cc\\)\\.\\ \\ soft\\ tissue\\ asymmetry\\ superior\\ to\\ left\\ vallecula\\ \\-\\ mass\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ neck\\ mri\\:\\ enhancing\\ plaque\\-like\\ mass\\ measuring\\ 0\\.9\\ x\\ 2\\.2\\ x\\ 3\\.4\\ cm\\ at\\ base\\ of\\ the\\ tongue\\.\\ \\ a\\ second\\ enhancing\\ mucosal\\ plaque\\-like\\ lesion\\ at\\ same\\ level\\ of\\ tongue\\ base\\ to\\ the\\ right\\ of\\ midline\\ measuring\\ 1\\.5cm\\ \\(trans\\)\\ x\\ 2\\.9cm\\ \\(cc\\)\\ x\\ 6mm\\ thick\\.\\ \\ masses\\ do\\ not\\ appear\\ to\\ extend\\ into\\ musculature\\ of\\ tongue\\.\\ \\ hemorrhagic\\ and\\ necrotic\\ lymph\\ node\\ in\\ level\\ 1\\ left\\ side\\ just\\ inferior\\ to\\ mandible\\ and\\ deep\\ portion\\ of\\ parotid\\ lateral\\ to\\ carotids\\ measuring\\ 3\\ x\\ 1\\.8\\ x\\ 3\\.8cm\\.\\ \\ second\\ necrotic\\ node\\ above\\ previous\\ measuring\\ 1\\.1\\ x\\ 1\\.3\\ x\\ 1\\.6cm\\.\ \(0\)\
\-\ oropharyngeal\\ \\(tongue\\)\\ cancer\\,\\ squamous\\ cell\\ carcinoma\\ \\(scc\\)\ \(0\)\
\-\ \\Â\\»\\ neoplasm\\ \\-\\ primary\\ vs\\ metastatic\ \(0\)\
\-\ \\Â\\»\\ infection\ \(0\)\
\-\ \\Â\\»\\ connective\\ tissue\\ disorder\ \(0\)\
\-\ \\Â\\»\\ vasculitis\ \(0\)\
\-\ \\Â\\»\\ other\\ autoimmune\\ disease\ \(0\)\
\-\ \\Â\\»\\ other\\ inflammatory\\ process\ \(0\)\
\-\ hpi\\:\\ presented\\ with\\ a\\ 6\\ month\\ hisotry\\ of\\ an\\ asymptomatic\\ left\\ neck\\ mass\\ s\\/p\\ failed\\ course\\ of\\ abx\\ therapy\\ and\\ two\\ non\\-diagnostic\\ fnas\\.\ \(0\)\
\-\ pmh\\:\\ denies\\ any\\ h\\/o\\ ca\\,\\ xrt\\,\\ chemo\\.\\ \\ denies\\ any\\ h\\/o\\ heart\\ dz\\,\\ lung\\ dz\\,\\ dm\\,\\ sle\\,\\ scleroderma\\,\\ or\\ ibd\\.\ \(0\)\
\-\ psh\\:\\ t\\&a\\ at\\ 6\\;\\ btl\\ at\\ 41\\;\\ right\\ foot\\ surgery\\ at\\ 51\\.\ \(0\)\
\-\ fhx\\:\\ mom\\ h\\/o\\ uterine\\ and\\ colon\\ ca\\;\\ 3\\ sisters\\ h\\/o\\ breast\\ ca\\;\\ sister\\ h\\/o\\ uterine\\ ca\\;\\ sister\\ h\\/o\\ breast\\ and\\ kidney\\ ca\\,\\ died\\ at\\ 52\\;\\ brother\\ died\\ of\\ lung\\ ca\\ at\\ 52\ \(0\)\
\-\ allergies\\:\\ nkda\ \(0\)\
\-\ meds\\:\\ tylenol\ \(0\)\
\-\ shx\\:\\ g4p4\\,\\ postmenopausal\\;\\ lifetime\\ non\\-smoker\\,\\ non\\-drinker\\;\\ no\\ significant\\ travel\\ or\\ occupational\\ exposure\\ history\ \(0\)\
\-\ ros\\:\\ pos\\ for\\ globus\\ sensation\\.\\ \\ denies\\ weight\\ loss\\,\\ pain\\,\\ hoarseness\\,\\ dysphagia\\,\\ constitutional\\ symptoms\\.\ \(0\)\
\-\ this\\ patient\\ is\\ unique\\ given\\ a\\ lack\\ of\\ any\\ classic\\ risk\\ factors\\ for\\ oropharyngeal\\ cancer\\.\\ \\ however\\,\\ her\\ extensive\\ family\\ history\\ of\\ cancer\\ raises\\ the\\ question\\ of\\ a\\ familial\\ risk\\ factor\\.\\ \\ although\\ oropharyngeal\\ squamous\\ cell\\ carcinoma\\ is\\ not\\ classically\\ related\\ to\\ any\\ of\\ the\\ other\\ cancers\\ her\\ mother\\ and\\ siblings\\ sufferred\\ from\\,\\ the\\ same\\ overexpression\\ or\\ underexpression\\ of\\ cell\\ cycle\\ regulators\\ and\\ tumor\\ suppressors\\ implicated\\ in\\ the\\ pathogenesis\\ of\\ those\\ cancers\\ are\\ being\\ studied\\ as\\ playing\\ a\\ role\\ in\\ oropharyngeal\\ carcinogenesis\\ as\\ well\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ca\\:\\ 0\\.23641341588602752\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.2348057889960696\ \(0\)\
\-\ tongue\\:\\ 0\\.1992285476543267\ \(0\)\
\-\ measuring\\:\\ 0\\.17863671296306982\ \(0\)\
\-\ parotid\\:\\ 0\\.16445654247782712\ \(0\)\
\-\ chemoradiation\\:\\ 0\\.1364875587130761\ \(0\)\
\-\ of\\:\\ 0\\.1355649153442954\ \(0\)\
\-\ lifetime\\:\\ 0\\.12335705748383134\ \(0\)\
\-\ at\\:\\ 0\\.12210533131833369\ \(0\)\
\-\ any\\:\\ 0\\.11938665750888032\ \(0\)\
\-\ dz\\:\\ 0\\.11508581990178054\ \(0\)\
\-\ trans\\:\\ 0\\.1130591907670545\ \(0\)\
\-\ neck\\:\\ 0\\.11300383426566331\ \(0\)\
\-\ denies\\:\\ 0\\.11174186827744408\ \(0\)\
\-\ sister\\:\\ 0\\.11125823637007498\ \(0\)\
\-\ to\\:\\ 0\\.10390923582861795\ \(0\)\
\-\ cancers\\:\\ 0\\.09920433040390483\ \(0\)\
\-\ for\\:\\ 0\\.09798238914158196\ \(0\)\
\-\ died\\:\\ 0\\.0969413189641275\ \(0\)\
\-\ and\\:\\ 0\\.09542995615860338\ \(0\)\
\-\ cancer\\:\\ 0\\.09228192265946286\ \(0\)\
\-\ necrotic\\:\\ 0\\.08991341115102151\ \(0\)\
\-\ cc\\:\\ 0\\.08946360721800523\ \(0\)\
\-\ uterine\\:\\ 0\\.08625474614421501\ \(0\)\
\-\ 52\\:\\ 0\\.08554289963192718\ \(0\)\
\-\ level\\:\\ 0\\.08369024557388711\ \(0\)\
\-\ squamous\\:\\ 0\\.0831216967004618\ \(0\)\
\-\ or\\:\\ 0\\.08032990427352077\ \(0\)\
\-\ node\\:\\ 0\\.07938908059830732\ \(0\)\
\-\ cell\\:\\ 0\\.07925511638730133\ \(0\)\
\-\ left\\:\\ 0\\.07876885579614\ \(0\)\
\-\ patient\\:\\ 0\\.0751038302246144\ \(0\)\
\-\ t2n2am0\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ amifostine\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ hisotry\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ btl\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ shx\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ g4p4\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ sufferred\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ underexpression\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ regulators\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ suppressors\\:\\ 0\\.07385546438466259\ \(0\)\
\-\ same\\:\\ 0\\.07306371437598294\ \(0\)\
\-\ other\\:\\ 0\\.07194954454559703\ \(0\)\
\-\ nasopharyngoscope\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ liklihood\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ imrt\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ digastric\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ vallecula\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ fnas\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ pos\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ overexpression\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ carcinogenesis\\:\\ 0\\.0705728390773514\ \(0\)\
\-\ mass\\:\\ 0\\.07056153967114129\ \(0\)\
\-\ base\\:\\ 0\\.07025994687447105\ \(0\)\
\-\ second\\:\\ 0\\.0691473383755818\ \(0\)\
\-\ breast\\:\\ 0\\.06707241398784619\ \(0\)\
\-\ sisters\\:\\ 0\\.066437220286326\ \(0\)\
\-\ risk\\:\\ 0\\.06599614412142801\ \(0\)\
\-\ iva\\:\\ 0\\.06496115404922687\ \(0\)\
\-\ chose\\:\\ 0\\.06496115404922687\ \(0\)\
\-\ the\\:\\ 0\\.06450521956490805\ \(0\)\
\-\ postmenopausal\\:\\ 0\\.06371315782804476\ \(0\)\
\-\ given\\:\\ 0\\.0635373830137529\ \(0\)\
\-\ studied\\:\\ 0\\.06263209432841353\ \(0\)\
\-\ fhx\\:\\ 0\\.06167852874191567\ \(0\)\
\-\ accepted\\:\\ 0\\.060825535258201474\ \(0\)\
\-\ opted\\:\\ 0\\.060825535258201474\ \(0\)\
\-\ siblings\\:\\ 0\\.060825535258201474\ \(0\)\
\-\ hpi\\:\\ 0\\.0600539087926596\ \(0\)\
\-\ implicated\\:\\ 0\\.0600539087926596\ \(0\)\
\-\ will\\:\\ 0\\.059448257476643625\ \(0\)\
\-\ abx\\:\\ 0\\.0587014472490174\ \(0\)\
\-\ disease\\:\\ 0\\.05815699801367483\ \(0\)\
\-\ chemo\\:\\ 0\\.058101472799920235\ \(0\)\
\-\ enhancing\\:\\ 0\\.057860841922330264\ \(0\)\
\-\ her\\:\\ 0\\.05770409432530079\ \(0\)\
\-\ carotids\\:\\ 0\\.05754290995089027\ \(0\)\
\-\ brother\\:\\ 0\\.05754290995089027\ \(0\)\
\-\ primary\\:\\ 0\\.0567941976379498\ \(0\)\
\-\ scc\\:\\ 0\\.05652959538352725\ \(0\)\
\-\ ibd\\:\\ 0\\.05652959538352725\ \(0\)\
\-\ nkda\\:\\ 0\\.05652959538352725\ \(0\)\
\-\ globus\\:\\ 0\\.05652959538352725\ \(0\)\
\-\ lung\\:\\ 0\\.056186387390032254\ \(0\)\
\-\ raises\\:\\ 0\\.05606684371379114\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05524826370672379\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.055213850230076945\ \(0\)\
\-\ however\\:\\ 0\\.054668979476921314\ \(0\)\
\-\ mom\\:\\ 0\\.05444222376453507\ \(0\)\
\-\ travel\\:\\ 0\\.05444222376453507\ \(0\)\
\-\ psh\\:\\ 0\\.05408234451018828\ \(0\)\
\-\ tylenol\\:\\ 0\\.05408234451018828\ \(0\)\
\-\ occupational\\:\\ 0\\.05408234451018828\ \(0\)\
\-\ ros\\:\\ 0\\.05408234451018828\ \(0\)\
\-\ hoarseness\\:\\ 0\\.05408234451018828\ \(0\)\
\-\ xrt\\:\\ 0\\.05308976222089287\ \(0\)\
\-\ cycle\\:\\ 0\\.05308976222089287\ \(0\)\
\-\ constitutional\\:\\ 0\\.052784218406479955\ \(0\)\
\-\ unique\\:\\ 0\\.051931224922765744\ \(0\)\
\-\ autoimmune\\:\\ 0\\.051665760151399315\ \(0\)\
\-\ dm\\:\\ 0\\.051665760151399315\ \(0\)\
\-\ scleroderma\\:\\ 0\\.051665760151399315\ \(0\)\
\-\ 6mm\\:\\ 0\\.05140872427216448\ \(0\)\
\-\ meds\\:\\ 0\\.05045515868566662\ \(0\)\
\-\ musculature\\:\\ 0\\.05023333795617421\ \(0\)\
\-\ familial\\:\\ 0\\.05023333795617421\ \(0\)\
\-\ surgery\\:\\ 0\\.04965905693401107\ \(0\)\
\-\ morbidity\\:\\ 0\\.04960216520195242\ \(0\)\
\-\ asymmetry\\:\\ 0\\.04901666073018554\ \(0\)\
\-\ sle\\:\\ 0\\.04901666073018554\ \(0\)\
\-\ mandible\\:\\ 0\\.04883053873641054\ \(0\)\
\-\ sparing\\:\\ 0\\.04847065948206375\ \(0\)\
\-\ role\\:\\ 0\\.04847065948206375\ \(0\)\
\-\ tissue\\:\\ 0\\.048452330062457166\ \(0\)\
\-\ allergies\\:\\ 0\\.04829654631644031\ \(0\)\
\-\ classically\\:\\ 0\\.04829654631644031\ \(0\)\
\-\ connective\\:\\ 0\\.047959166243302404\ \(0\)\
\-\ question\\:\\ 0\\.04763528504809152\ \(0\)\
\-\ monitor\\:\\ 0\\.047172533378355426\ \(0\)\
\-\ failed\\:\\ 0\\.0465940051673917\ \(0\)\
\-\ notable\\:\\ 0\\.04618571948984635\ \(0\)\
\-\ have\\:\\ 0\\.0461411295458328\ \(0\)\
\-\ in\\:\\ 0\\.045954575460032406\ \(0\)\
\-\ combined\\:\\ 0\\.04579703924403995\ \(0\)\
\-\ excluded\\:\\ 0\\.0454261675234272\ \(0\)\
\-\ playing\\:\\ 0\\.04473180360900261\ \(0\)\
\-\ thick\\:\\ 0\\.043889908071044224\ \(0\)\
\-\ exposure\\:\\ 0\\.043889908071044224\ \(0\)\
\-\ mucosal\\:\\ 0\\.043499666257066125\ \(0\)\
\-\ factor\\:\\ 0\\.04331137986008051\ \(0\)\
\-\ possibility\\:\\ 0\\.04294745566427505\ \(0\)\
\-\ vasculitis\\:\\ 0\\.04285897445393922\ \(0\)\
\-\ extend\\:\\ 0\\.042599189058576375\ \(0\)\
\-\ 41\\:\\ 0\\.042347481215177875\ \(0\)\
\-\ dissection\\:\\ 0\\.04194461451384629\ \(0\)\
\-\ firm\\:\\ 0\\.04186639216464382\ \(0\)\
\-\ pmh\\:\\ 0\\.04178891836614792\ \(0\)\
\-\ dysphagia\\:\\ 0\\.04171217892750204\ \(0\)\
\-\ options\\:\\ 0\\.041636160057604024\ \(0\)\
\-\ still\\:\\ 0\\.04091282657814596\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.040059833094431764\ \(0\)\
\-\ sensation\\:\\ 0\\.039576349146628026\ \(0\)\
\-\ lack\\:\\ 0\\.039517894378883846\ \(0\)\
\-\ those\\:\\ 0\\.039517894378883846\ \(0\)\
\-\ mother\\:\\ 0\\.039459858645334585\ \(0\)\
\-\ disorder\\:\\ 0\\.03906485590786668\ \(0\)\
\-\ factors\\:\\ 0\\.03906485590786668\ \(0\)\
\-\ do\\:\\ 0\\.038278223042919696\ \(0\)\
\-\ is\\:\\ 0\\.03794196504003849\ \(0\)\
\-\ as\\:\\ 0\\.037106094048366706\ \(0\)\
\-\ recurrent\\:\\ 0\\.037030226821737594\ \(0\)\
\-\ just\\:\\ 0\\.036945005506819714\ \(0\)\
\-\ stage\\:\\ 0\\.036777207787120555\ \(0\)\
\-\ foot\\:\\ 0\\.03649167869281753\ \(0\)\
\-\ not\\:\\ 0\\.036463303889452924\ \(0\)\
\-\ nodule\\:\\ 0\\.036451698610773874\ \(0\)\
\-\ excision\\:\\ 0\\.036411914991842466\ \(0\)\
\-\ appear\\:\\ 0\\.03637232591461215\ \(0\)\
\-\ family\\:\\ 0\\.036332929485721754\ \(0\)\
\-\ deep\\:\\ 0\\.03594916332210637\ \(0\)\
\-\ lymph\\:\\ 0\\.03591176856665696\ \(0\)\
\-\ extensive\\:\\ 0\\.035582768212147405\ \(0\)\
\-\ history\\:\\ 0\\.03528858257411654\ \(0\)\
\-\ vs\\:\\ 0\\.0352322394306334\ \(0\)\
\-\ colon\\:\\ 0\\.035163918770660364\ \(0\)\
\-\ related\\:\\ 0\\.03509616983839217\ \(0\)\
\-\ are\\:\\ 0\\.03504812358732944\ \(0\)\
\-\ previous\\:\\ 0\\.03489625967751302\ \(0\)\
\-\ midline\\:\\ 0\\.03473335780003898\ \(0\)\
\-\ process\\:\\ 0\\.03463716716162007\ \(0\)\
\-\ about\\:\\ 0\\.0345736691877909\ \(0\)\
\-\ classic\\:\\ 0\\.03454210598928966\ \(0\)\
\-\ course\\:\\ 0\\.034112674642350585\ \(0\)\
\-\ above\\:\\ 0\\.03331664234641856\ \(0\)\
\-\ ap\\:\\ 0\\.03315579036338523\ \(0\)\
\-\ portion\\:\\ 0\\.03302414599681367\ \(0\)\
\-\ kidney\\:\\ 0\\.032444717285302765\ \(0\)\
\-\ weight\\:\\ 0\\.03220517465856004\ \(0\)\
\-\ being\\:\\ 0\\.03218160564581196\ \(0\)\
\-\ heart\\:\\ 0\\.03211130751821445\ \(0\)\
\-\ new\\:\\ 0\\.0319496141233222\ \(0\)\
\-\ side\\:\\ 0\\.03190400301585845\ \(0\)\
\-\ this\\:\\ 0\\.03173810242407929\ \(0\)\
\-\ benign\\:\\ 0\\.03172408560802599\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03152634565226937\ \(0\)\
\-\ masses\\:\\ 0\\.03143998803174652\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.03143998803174652\ \(0\)\
\-\ although\\:\\ 0\\.03143998803174652\ \(0\)\
\-\ inferior\\:\\ 0\\.031418541793613065\ \(0\)\
\-\ inflammatory\\:\\ 0\\.031228040059314094\ \(0\)\
\-\ right\\:\\ 0\\.030622650393943983\ \(0\)\
\-\ medial\\:\\ 0\\.030061139175565986\ \(0\)\
\-\ superior\\:\\ 0\\.030024996480891582\ \(0\)\
\-\ adjacent\\:\\ 0\\.029935339416641494\ \(0\)\
\-\ severe\\:\\ 0\\.029235358995327032\ \(0\)\
\-\ only\\:\\ 0\\.028852047162650395\ \(0\)\
\-\ loss\\:\\ 0\\.028135916486301867\ \(0\)\
\-\ month\\:\\ 0\\.028093193695016127\ \(0\)\
\-\ infection\\:\\ 0\\.027896748524629037\ \(0\)\
\-\ weeks\\:\\ 0\\.027677925740055575\ \(0\)\
\-\ region\\:\\ 0\\.027624131853361895\ \(0\)\
\-\ two\\:\\ 0\\.027425529494789297\ \(0\)\
\-\ presented\\:\\ 0\\.026930869703573425\ \(0\)\
\-\ significant\\:\\ 0\\.026664611172692542\ \(0\)\
\-\ therapy\\:\\ 0\\.02653469525322105\ \(0\)\
\-\ cm\\:\\ 0\\.02652298744183706\ \(0\)\
\-\ metastatic\\:\\ 0\\.02532865140159623\ \(0\)\
\-\ symptoms\\:\\ 0\\.025268308636568475\ \(0\)\
\-\ soft\\:\\ 0\\.024586444728269218\ \(0\)\
\-\ into\\:\\ 0\\.024549686662122427\ \(0\)\
\-\ tumor\\:\\ 0\\.024155993842974847\ \(0\)\
\-\ mri\\:\\ 0\\.023705867060592228\ \(0\)\
\-\ exam\\:\\ 0\\.023248165460586476\ \(0\)\
\-\ lateral\\:\\ 0\\.022919234195645247\ \(0\)\
\-\ surgical\\:\\ 0\\.022446077756245297\ \(0\)\
\-\ well\\:\\ 0\\.02236167090833779\ \(0\)\
\-\ lesion\\:\\ 0\\.02214079582380238\ \(0\)\
\-\ treatment\\:\\ 0\\.021999054017946426\ \(0\)\
\-\ has\\:\\ 0\\.02109470408551002\ \(0\)\
\-\ be\\:\\ 0\\.01873429071492683\ \(0\)\
\-\ from\\:\\ 0\\.018341629970395065\ \(0\)\
\-\ an\\:\\ 0\\.017659935640063733\ \(0\)\
\-\ ct\\:\\ 0\\.017582014440271198\ \(0\)\
\-\ pain\\:\\ 0\\.01652570699064091\ \(0\)\
\-\ was\\:\\ 0\\.01609496976630141\ \(0\)\
\-\ no\\:\\ 0\\.015017940726394431\ \(0\)\
\-\ with\\:\\ 0\\.009043061023260685\ \(0\)\
\-\ can\\:\\ 0\\.0\ \(0\)\
